- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Hyphens Pharma International Ltd (HYPH)
Hyphens Pharma International Ltd stock price live, this page displays SGX HYPH stock exchange data. View the HYPH premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Hyphens Pharma International Ltd real time stock price chart below.
What Is the Hyphens Pharma International Ltd Stock Price Today?
The Hyphens Pharma International Ltd stock price today is 0.340.
What Is the Stock Symbol for Hyphens Pharma International Ltd?
The stock symbol for Hyphens Pharma International Ltd is "HYPH."
What Stock Exchange Does Hyphens Pharma International Ltd Trade On?
Hyphens Pharma International Ltd is listed and trades on the Singapore stock exchange.
Is Hyphens Pharma International Ltd a Good Stock to Buy?
Determining whether Hyphens Pharma International Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the HYPH quote. (ISIN: SG1EE4000006)
What Is the Hyphens Pharma International Ltd Stock Price Today?
The Hyphens Pharma International Ltd stock price today is 0.340.
What Is the Stock Symbol for Hyphens Pharma International Ltd?
The stock symbol for Hyphens Pharma International Ltd is "HYPH."
What Stock Exchange Does Hyphens Pharma International Ltd Trade On?
Hyphens Pharma International Ltd is listed and trades on the Singapore stock exchange.
Is Hyphens Pharma International Ltd a Good Stock to Buy?
Determining whether Hyphens Pharma International Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the HYPH quote. (ISIN: SG1EE4000006)
Singapore
Currency in SGD
0.340
0.000(0.00%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.335
0.340
52 wk Range
0.260
0.395
High dividend Yield
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.3350.340
52 wk Range
0.2600.395
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(4.41%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(4.41%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
HYPH Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
0.415
Upside
+22.06%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low revenue valuation multiple
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Hyphens Pharma International Ltd Company Profile
Hyphens Pharma International Limited, together with its subsidiaries, operates as a specialty pharmaceutical and consumer healthcare company primarily in Singapore, Vietnam, Malaysia, and internationally. It operates through Specialty pharma principals; Proprietary brands; and Medical hypermart and digital segments. The Specialty Pharma Principals segment markets and sells specialty pharmaceutical products, including contrast media products, Stérimar nasal sprays, Bausch+Lomb eye drops, Vivomixx, Fenosup Lidose, and Piascledine products through distributorship or licensing, and supply agreements for the therapeutic areas, including dermatology, pediatrics and neonatology, allergy, otorhinolaryngology, orthopedics and rheumatology, radiology, cardiology and interventional cardiology, ophthalmology, gastroenterology, psychiatry, family medicine, and medical aesthetics. The Proprietary Brands segment develops, markets, and sells dermatological products, such as Cerdan, TDF, and CG 210 for the treatment of atopic dermatitis, acne, aging skin, and hyperpigmentation, as well as health supplement products under the Ocean Health brand name for heart, joint, physical, cognitive, eye, and children's health. The Medical Hypermart and Digital segment wholesales pharmaceuticals and medical supplies for healthcare professionals and institutions, and retail pharmacies through tele sales, direct sales, and online B2B platform. The company was formerly known as Hyphens Pharma International Pte Ltd and changed its name to Hyphens Pharma International Limited in May 2018. Hyphens Pharma International Limited was founded in 1998 and is headquartered in Singapore.
Compare HYPH to Peers and Sector
Metrics to compare | HYPH | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipHYPHPeersSector | |
|---|---|---|---|---|
P/E Ratio | 16.3x | 22.5x | −0.6x | |
PEG Ratio | −0.42 | 0.50 | 0.00 | |
Price/Book | 1.6x | 2.9x | 2.6x | |
Price / LTM Sales | 0.6x | 3.9x | 3.4x | |
Upside (Analyst Target) | 22.1% | 24.6% | 42.0% | |
Fair Value Upside | Unlock | 14.5% | 5.8% | Unlock |
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 0.415
(+22.06% Upside)
Earnings
Latest Release
Nov 28, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
FAQ
What Is the Hyphens Pharma (HYPH) Stock Price Today?
The Hyphens Pharma stock price today is 0.340
What Stock Exchange Does Hyphens Pharma Trade On?
Hyphens Pharma is listed and trades on the Singapore Stock Exchange stock exchange.
What Is the Stock Symbol for Hyphens Pharma?
The stock symbol for Hyphens Pharma is "HYPH."
Does Hyphens Pharma Pay Dividends? What’s The Current Dividend Yield?
The Hyphens Pharma dividend yield is 4.41%.
What Is the Hyphens Pharma Market Cap?
As of today, Hyphens Pharma market cap is 105.02M.
What Is Hyphens Pharma's Earnings Per Share (TTM)?
The Hyphens Pharma EPS (TTM) is 0.02.
When Is the Next Hyphens Pharma Earnings Date?
Hyphens Pharma will release its next earnings report on Mar 03, 2026.
From a Technical Analysis Perspective, Is HYPH a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Hyphens Pharma Stock Split?
Hyphens Pharma has split 0 times.
How Many Employees Does Hyphens Pharma Have?
Hyphens Pharma has 465 employees.
What is the current trading status of Hyphens Pharma (HYPH)?
As of Jan 22, 2026, Hyphens Pharma (HYPH) is trading at a price of 0.340, with a previous close of 0.340. The stock has fluctuated within a day range of 0.335 to 0.340, while its 52-week range spans from 0.260 to 0.395.
What Is Hyphens Pharma (HYPH) Price Target According to Analysts?
The average 12-month price target for Hyphens Pharma is SGD0.415, with a high estimate of SGD0.43 and a low estimate of SGD0.4. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +22.06% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.